Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study

被引：0
|
作者：
J. Rosenstock
V. Fonseca
J. B. McGill
M. Riddle
J.-P. Hallé
I. Hramiak
P. Johnston
M. Davis
机构：
[1] Dallas Diabetes and Endocrine Center at Medical City,
[2] University of Texas Southwestern Medical School,undefined
[3] Tulane University Medical Center,undefined
[4] Washington University School of Medicine,undefined
[5] Oregon Health and Science University,undefined
[6] Université de Montréal,undefined
[7] University of Western Ontario,undefined
[8] sanofi-aventis,undefined
[9] University of Wisconsin School of Medicine and Public Health,undefined
来源：
Diabetologia | 2009年 / 52卷
关键词：
CSME; ETDRS; Insulin action; Insulin glargine; Insulin therapy; NPH insulin; Retinopathy; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1778 / 1788
页数：10
相关论文
共 50 条
  • [31] Cost-effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Portugal
    Cardoso, Cristina
    Ramirez de Arellano, Antonio
    Prades, Miriam
    Lizan, Luis
    [J]. JOURNAL OF DIABETES & METABOLISM, 2016, 7 (03)
  • [32] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Cristóbal Morales
    Daniel de Luis
    Antonio Ramírez de Arellano
    Maria Giovanna Ferrario
    Luis Lizán
    [J]. Diabetes Therapy, 2015, 6 : 593 - 610
  • [33] A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: Subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study
    Fonseca, V
    Bell, DS
    Berger, S
    Thomson, S
    Mecca, TE
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (05): : 274 - 280
  • [34] Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis
    Lee, Pearl
    Chang, Annette
    Blaum, Caroline
    Vlajnic, Aleksandra
    Gao, Ling
    Halter, Jeffrey
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 (01) : 51 - 59
  • [35] Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes
    Rhoads, G. G.
    Dain, M. P.
    Zhang, Q.
    Kennedy, L.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (08): : 711 - 717
  • [36] Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial
    Aschner, Pablo
    Chan, Juliana
    Owens, David R.
    Picard, Sylvie
    Wang, Edward
    Dain, Marie-Paule
    Pilorget, Valerie
    Echtay, Akram
    Fonseca, Vivian
    [J]. LANCET, 2012, 379 (9833): : 2262 - 2269
  • [37] Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study
    Wang, Li
    Wei, Wenhui
    Miao, Raymond
    Xie, Lin
    Baser, Onur
    [J]. BMJ OPEN, 2013, 3 (04):
  • [38] Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes
    Bladbjerg, E. M.
    Henriksen, J. E.
    Akram, S.
    Gram, J.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (05): : 447 - 453
  • [39] REAL-WORLD HEALTH CARE UTILIZATION, PRODUCTIVITY AND ASSOCIATED COSTS AMONG EMPLOYEES WITH TYPE 2 DIABETES MELLITUS TREATED WITH INSULIN GLARGINE OR NEUTRAL PROTAMINE HAGEDORN (NPH) INSULIN IN THE UNITED STATES
    Wang, L.
    Wei, W.
    Miao, R.
    Xie, L.
    Baser, O.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A176 - A176
  • [40] Long-term glycaemic control with insulin glargine in Type 2 diabetes
    Kacerovsky-Bielesz, G
    Dressler, A
    Freunscht, R
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (02) : 184 - 191
12345